These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 28146614)

  • 21. Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis.
    Zhang JP; Gallego JA; Robinson DG; Malhotra AK; Kane JM; Correll CU
    Int J Neuropsychopharmacol; 2013 Jul; 16(6):1205-18. PubMed ID: 23199972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An assessment of emergent tardive dyskinesia and existing dyskinesia in patients receiving long-acting, injectable risperidone: results from a long-term study.
    Gharabawi GM; Bossie CA; Zhu Y; Mao L; Lasser RA
    Schizophr Res; 2005 Sep; 77(2-3):129-39. PubMed ID: 15913962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tardive dyskinesia and tardive dystonia with second-generation antipsychotics in non-elderly schizophrenic patients unexposed to first-generation antipsychotics: a cross-sectional and retrospective study.
    Ryu S; Yoo JH; Kim JH; Choi JS; Baek JH; Ha K; Kwon JS; Hong KS
    J Clin Psychopharmacol; 2015 Feb; 35(1):13-21. PubMed ID: 25485636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Phenotype of Tardive Dyskinesia in Bipolar Disorder.
    Gardea-Resendez M; Taylor-Desir MJ; Romo-Nava F; Bond D; Vallender EJ; Cuellar-Barboza AB; Prieto ML; Nunez N; Veldic M; Ozerdem A; Singh B; Markota M; Colby CL; Coombes BJ; Biernacka JM; McElroy SL; Frye MA
    J Clin Psychopharmacol; 2022 Mar-Apr 01; 42(2):159-162. PubMed ID: 35230047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The METEOR study: frequency of metabolic disorders in patients with schizophrenia. Focus on first and second generation and level of risk of antipsychotic drugs.
    Falissard B; Mauri M; Shaw K; Wetterling T; Doble A; Giudicelli A; De Hert M
    Int Clin Psychopharmacol; 2011 Nov; 26(6):291-302. PubMed ID: 21876442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and correlates of antipsychotic polypharmacy: a systematic review and meta-regression of global and regional trends from the 1970s to 2009.
    Gallego JA; Bonetti J; Zhang J; Kane JM; Correll CU
    Schizophr Res; 2012 Jun; 138(1):18-28. PubMed ID: 22534420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequency and correlates of tardive dyskinesia in Indian patients with type I bipolar disorder.
    Rajan TM; Bharadwaj B; Rajkumar RP; Adole PS
    Asian J Psychiatr; 2018 Feb; 32():92-98. PubMed ID: 29222987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Switching antipsychotic treatment to aripiprazole in psychotic patients with neuroleptic-induced tardive dyskinesia: a 24-week follow-up study.
    Chan CH; Chan HY; Chen YC
    Int Clin Psychopharmacol; 2018 May; 33(3):155-162. PubMed ID: 29324468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antipsychotic-induced tardive syndromes].
    Fleischhacker WW; Hofer A; Jagsch C; Pirker W; Psota G; Rittmannsberger H; Seppi K
    Neuropsychiatr; 2016 Sep; 30(3):123-130. PubMed ID: 27580887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of tardive dyskinesia in older adult patients treated with olanzapine or conventional antipsychotics.
    Kinon BJ; Kollack-Walker S; Jeste D; Gupta S; Chen L; Case M; Chen J; Stauffer V
    J Geriatr Psychiatry Neurol; 2015 Mar; 28(1):67-79. PubMed ID: 25009161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determining Whether a Definitive Causal Relationship Exists Between Aripiprazole and Tardive Dyskinesia and/or Dystonia in Patients With Major Depressive Disorder, Part 3: Clinical Trial Data.
    Preskorn SH; Macaluso M
    J Psychiatr Pract; 2016 Mar; 22(2):117-23. PubMed ID: 27138080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of and Risk Factors for Extrapyramidal Side Effects of Antipsychotics: Results From the National FACE-SZ Cohort.
    Misdrahi D; Tessier A; Daubigney A; Meissner WG; Schurhoff F; Boyer L; Godin O; Bulzacka E; Aouizerate B; Andrianarisoa M; Berna F; Capdevielle D; Chereau-Boudet I; D'Amato T; Dubertret C; Dubreucq J; Faget-Agius C; Lançon C; Mallet J; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Llorca PM; Fond G;
    J Clin Psychiatry; 2019 Jan; 80(1):. PubMed ID: 30695288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cumulative Burden of Illness in Veterans With Tardive Dyskinesia and Serious Mental Disorders.
    Caroff SN; Leong SH; Roberts C; Berkowitz RM; Campbell EC
    J Clin Psychopharmacol; 2020; 40(1):38-45. PubMed ID: 31834084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antipsychotic-induced tardive dyskinesia: update on epidemiology and management.
    Widschwendter CG; Hofer A
    Curr Opin Psychiatry; 2019 May; 32(3):179-184. PubMed ID: 30720484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends, correlates, and disease patterns of antipsychotic use among children and adolescents in Taiwan.
    Hsu YC; Chien IC; Tan HK; Lin CH; Cheng SW; Chou YJ; Chou P
    Soc Psychiatry Psychiatr Epidemiol; 2013 Dec; 48(12):1889-96. PubMed ID: 23653092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A meta-analysis of the efficacy of second-generation antipsychotics.
    Davis JM; Chen N; Glick ID
    Arch Gen Psychiatry; 2003 Jun; 60(6):553-64. PubMed ID: 12796218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacotherapy for the treatment of tardive dyskinesia in schizophrenia patients.
    Witter DP; Holbert RC; Suryadevara U
    Expert Opin Pharmacother; 2017 Jul; 18(10):965-972. PubMed ID: 28443349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tardive dyskinesia and new antipsychotics.
    Correll CU; Schenk EM
    Curr Opin Psychiatry; 2008 Mar; 21(2):151-6. PubMed ID: 18332662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparing acute toxicity of first- and second-generation antipsychotic drugs: a 10-year, retrospective cohort study.
    Ciranni MA; Kearney TE; Olson KR
    J Clin Psychiatry; 2009 Jan; 70(1):122-9. PubMed ID: 19192473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tardive dyskinesia: determinants of temporal dynamics of its emergence.
    Latalova K
    Neuro Endocrinol Lett; 2008 Dec; 29(6):995-8. PubMed ID: 19112392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.